News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
831,282 Results
Type
Article (85534)
Company Profile (697)
Press Release (745051)
Section
Business (232203)
Career Advice (4106)
Deals (39645)
Drug Delivery (116)
Drug Development (90613)
Employer Resources (194)
FDA (17954)
Job Trends (17272)
News (395445)
Policy (39607)
Tag
Academia (2975)
Alliances (56452)
Alzheimer's disease (1331)
Approvals (17871)
Artificial intelligence (157)
Bankruptcy (394)
Best Places to Work (12516)
Biotechnology (480)
Breast cancer (125)
Cancer (1131)
Cardiovascular disease (101)
Career advice (3513)
Cell therapy (267)
Clinical research (71492)
Collaboration (415)
Compensation (202)
COVID-19 (2800)
C-suite (101)
Data (1147)
Diabetes (151)
Diagnostics (6674)
Earnings (94687)
Employer resources (166)
Events (126716)
Executive appointments (323)
FDA (18506)
Funding (369)
Gene therapy (201)
GLP-1 (673)
Government (5039)
Healthcare (20699)
Infectious disease (2881)
Inflammatory bowel disease (121)
Interviews (807)
IPO (17592)
Job creations (5179)
Job search strategy (2855)
Layoffs (487)
Legal (10037)
Lung cancer (181)
Manufacturing (199)
Medical device (14405)
Medtech (14410)
Mergers & acquisitions (22097)
Metabolic disorders (439)
Neuroscience (1633)
NextGen Class of 2024 (7645)
Non-profit (5059)
Northern California (1502)
Obesity (249)
Opinion (244)
Patents (111)
People (64160)
Pharmaceutical (139)
Phase I (22012)
Phase II (31057)
Phase III (23401)
Pipeline (465)
Postmarket research (3537)
Preclinical (9956)
Radiopharmaceuticals (255)
Rare diseases (237)
Real estate (7373)
Regulatory (25933)
Research institute (2640)
Resumes & cover letters (648)
Southern California (1332)
Startups (4273)
United States (14352)
Vaccines (646)
Weight loss (204)
Date
Today (81)
Last 7 days (704)
Last 30 days (3876)
Last 365 days (38093)
2024 (34950)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (224)
Asia (49337)
Australia (8696)
California (3486)
Canada (1306)
China (264)
Colorado (152)
Connecticut (164)
Europe (112975)
Florida (456)
Georgia (114)
Illinois (403)
Indiana (211)
Kansas (103)
Maryland (625)
Massachusetts (2833)
Michigan (173)
Minnesota (289)
New Jersey (994)
New York (982)
North Carolina (837)
Northern California (1502)
Ohio (142)
Pennsylvania (860)
South America (1647)
Southern California (1332)
Texas (494)
Washington State (386)
831,282 Results for "rosemont pharmaceuticals ltd acquired by bio technology general corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
Nuvation Bio Inc. and AnHeart Therapeutics Ltd. today announced that the companies have entered into a definitive agreement for Nuvation Bio to acquire AnHeart in an all-stock transaction (the Acquisition).
March 25, 2024
·
11 min read
Press Releases
Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies
October 25, 2024
·
11 min read
Press Releases
Kapoose Creek Bio Acquires Exclusive License to Adapsyn Bioscience’s World-Leading AI Technology for Drug Development
October 30, 2024
·
3 min read
Protect Pharmaceutical Corp. Issues Corporate Update
Protect Pharmaceutical Corp.'s (OTC: PRTT) (“Company”) President, Ali Yildiz, provides its shareholders with the following informational update: “July 1, 2024 Dear Shareholders: The Company’s PCAOB audit for the fiscal year of 2023 is near completion.
July 1, 2024
·
4 min read
Press Releases
Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination
August 16, 2024
·
5 min read
Notice of Annual General Meeting (AGM) of Bioretec Ltd
The shareholders of Bioretec Ltd are hereby invited to the Annual General Meeting to be held on 26 April 2024 at 10:00 a.m.
April 5, 2024
·
14 min read
Press Releases
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration
October 31, 2024
·
8 min read
ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology
ImmunoPrecise Antibodies Ltd., a leader in AI-driven biotherapeutic research and technology, announces that its subsidiary, BioStrand, has been honored with the prestigious 2024 Impact Award, sponsored by InterSystems.
June 12, 2024
·
5 min read
BioMidwest
Apotex Corp. Launches Generic Fertility Treatment Injectable Cetrorelix® in the United States
Apotex Corp. announced the launch of Cetrorelix Acetate for Injection 0.25mg, a generic version of Cetrotide® in the United States.
May 14, 2024
·
1 min read
Pharm Country
Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that Jessica Morris, Chief Operating Officer, will present at the 2024 BIO International Convention being held June 3-6, 2024 in San Diego, Calif.
May 28, 2024
·
4 min read
1 of 83,129
Next
